Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 2

Liczba wyników na stronie
first rewind previous Strona / 1 next fast forward last
Wyniki wyszukiwania
Wyszukiwano:
w słowach kluczowych:  bioactive composite
help Sortuj według:

help Ogranicz wyniki do:
first rewind previous Strona / 1 next fast forward last
EN
The development of composite biomaterials constituting both a porous scaffold for filling tissue defects (especially bone tissue) and a carrier of biologically active substances (proteins) is an innovative approach of the presented research. The paper presents the following studies of obtained composites: model protein (bovine serum albumin, BSA) release, changes in microstructure during incubation and bioactive potential in a simulated biological environment (based on scanning electron microscopy with X-ray microanalysis – SEM/EDS – and infrared spectroscopy – FTIR). Three types of composites with a poly(L-lactide) matrix PLLA were investigated. PLA fibres covered with silica-calcium sol, calcium alginate fibres and calcium alginate beads were used as modifiers of the PLA matrix and carriers of protein. Process of releasing albumin proceeded differently depending on the material and form of the carrier. In the case of calcium alginate fibres, almost all protein was released within 14 days. For the remaining materials, this amount was reached after 3 weeks. All tested composites showed bioactive potential connected with apatite precipitation during incubation in a simulated biological environment. However, coating PLA fibres with silica-calcium sol significantly increased this effect. The highest cell viability was observed for a biomaterial modified by calcium alginate beads.
EN
Composites made of resorbable polylactide modified with bone powder are part of the current search for implantable materials endowed with advantageous biomechanical functions, which make them suitable for orthopedics and traumatology applications. The bone additive containing active bone morphogenetic proteins (BMPs) and calcium phosphates introduced into the polymer matrix is to grant the implant with a biological activity. Subsequently, the resorbable matrix should get replaced with bone tissue. In order to avoid losing the osteoinductive properties of the designed material, it should be processed at low temperatures via physicochemical methods. This paper is devoted to the preparation and optimization of the composite production method suitable for biodegradable polymers and morphogenetic proteins along with the assessment of biocompatibility and biological properties of obtained materials. The tape-casting method was successfully applied. Resorbable polymer (medical poly-L-lactide, Purasorb PL38 by Purac) with 15 wt% of human bone powder (from tissue bank) were used to fabricate PLA-CP/BMPs composite implants. They were tested in in vivo studies that were performed in rabbit bone tissues. The results show a high biocompatibility of the material and good osteointegration with bone tissue.
first rewind previous Strona / 1 next fast forward last
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.